Efficacy, Immunogenicity, and Safety of an Investigational Maternal Respiratory Syncytial Virus Prefusion F Protein–Based Vaccine
Peyman Banooni(Matrix Research (United States)), Marta Picciolato(GlaxoSmithKline (Belgium)), Martin O. C. Ota(GlaxoSmithKline (Belgium)), Cristina Epalza(Universidad Complutense de Madrid), Anu Kantele(University of Helsinki), Ilse Dieussaert, Bernard Gonik(Wayne State University), Cláudia Seidl(GlaxoSmithKline (Germany)), Grace Devota Gomez-Go(St. Mary's Hospital), Shabir A. Madhi(University of the Witwatersrand), Li‐Min Huang(National Taiwan University Hospital), J DEWULF(AZ Groeninge), Conrado J. Llapur(National University of Tucumán), Khalequ Zaman(International Centre for Diarrhoeal Disease Research), Marisa Márcia Mussi‐Pinhata(Universidade de São Paulo), Thorsten Stanley(Wellington Hospital), Joanne M. Langley(Dalhousie University), Bruno Anspach(GlaxoSmithKline (United States)), Joon Hyung Kim(GlaxoSmithKline (United States)), Eduardo López‐Medina(Universidad del Valle), Ouzama Henry(GlaxoSmithKline (United States)), Martha Kirabo(GlaxoSmithKline (Belgium)), Osvaldo Reyes
Cited by 7